Dietary Choices Modulate Colorectal Cancer Stem Cells: A Role of FXR Nuclear Receptor.

Nutrition and Cancer
Nilesh Kumar SharmaJayanta K Pal

Abstract

Intra- and inter-tumor heterogeneity (TMH) among colorectal cancer patients is considered as major hurdles to develop precise, potent, and personalized cancer therapeutics. The discernible factors that contribute to the existence of TMH and associated problems are suggested as genetic, molecular, epigenetic, and environmental pressures including shifts in trend from high-fiber diet to high-fat/processed sugar diet. In essence, components of high fat/processed sugar diet potentiate metabolic re-programing of inherent cellular heterogeneity of cancer stem cells (CSCs) by genetic and epigenetic pathways intersected by the farnesoid X receptor (FXR) nuclear receptor. Therefore, choices of dietary components shape up protumor or antitumor microenvironment by the modulation of FXR regulated transcriptional and epigenetic events in CSCs. In this article, we highlight the major understanding emanated from preclinical and clinical studies that indicate the potential contribution of high fiber/saturated sugar diet toward carcinogenesis of colorectal cancer.

References

May 21, 1999·Science·D J ParksJ M Lehmann
Mar 20, 2002·Nature Reviews. Cancer·R FoddeH Clevers
Apr 30, 2003·Molecular Cell·Michael DownesRonald M Evans
Jun 6, 2007·Proceedings of the National Academy of Sciences of the United States of America·Piero DalerbaMichael F Clarke
Apr 9, 2008·Proceedings of the National Academy of Sciences of the United States of America·Stephen M SoissonJoseph W Becker
Jul 30, 2008·Annals of Surgical Oncology·Naotsugu HaraguchiMasaki Mori
Aug 2, 2008·Nature Reviews. Drug Discovery·Charles ThomasKristina Schoonjans
Dec 3, 2008·Cancer Research·Salvatore ModicaAntonio Moschetta
Dec 19, 2008·Nature·Nick BarkerHans Clevers
Jul 5, 2011·Trends in Molecular Medicine·Chiara DegirolamoAntonio Moschetta
Nov 15, 2011·Nature Biotechnology·Piero DalerbaStephen R Quake
Oct 9, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·Hongying SuXiongfei Huang
Nov 23, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yanjun JiangNikolai A Timchenko
Jan 24, 2013·Veterinary Pathology·C V Löhr
Apr 27, 2016·Pharmacology & Therapeutics·Sathish SivaprakasamNagendra Singh
Sep 13, 2016·Oncogene·T ZhanM Boutros
Oct 6, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Semir Beyaz, Ömer H Yilmaz
Dec 14, 2016·Cancer Cell·Ting FuRonald M Evans
Feb 18, 2017·Molecular Cancer·Pramudita R Prasetyanti, Jan Paul Medema
Mar 9, 2017·Nature·Maria J Rodríguez-ColmanBoudewijn M T Burgering
Mar 25, 2017·Science·Cristian TomasettiBert Vogelstein
Mar 25, 2017·Stem Cells International·Eunice Yuen-Ting LauTerence Kin-Wah Lee
May 24, 2017·Carcinogenesis·Leila ValanejadNikolai Timchenko
Jun 21, 2017·Bioorganic & Medicinal Chemistry Letters·Hong WangXiaowei Xu
Aug 16, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·C-Z WangC-S Yuan
Sep 25, 2017·Journal of Clinical Pathology·Matthew J MunroTinte Itinteang
Oct 3, 2017·Current Stem Cell Reports·Miyeko D ManaÖmer H Yilmaz
Jun 6, 2018·Clinical Colorectal Cancer·Jiezhong Chen, Luis Vitetta
Jun 16, 2018·Frontiers in Nutrition·Fangxia GuanDerek M Huffman
Aug 10, 2018·Science Translational Medicine·Ömer H Yilmaz
Aug 28, 2018·Cancer Cell·Olivier Meurette, Patrick Mehlen
Oct 24, 2018·International Journal of Cancer. Journal International Du Cancer·J FerlayF Bray
Dec 12, 2018·Frontiers in Pharmacology·Wuwen FengCheng Peng
Feb 23, 2019·Cell·Ting FuRonald M Evans

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Related Papers

Histology and Histopathology
Ioannis KoutsounasS Theocharis
Acta Pharmacologica Sinica
Xiongfei HuangWendong Huang
Histology and Histopathology
Yan-Dong WangWendong Huang
© 2021 Meta ULC. All rights reserved